MA (EU) Number
(Invented) 
name
Strength Pharmaceutical 
Form
Route of 
Administration
Immediate Packaging Content 
Pack size
(concentration)
EU/1/17/1252/001 Fasenra  
30 mg
EU/1/17/1252/002 Fasenra
30 mg
Solution for 
injection
Solution for 
injection
Subcutaneous 
use
pre-filled syringe (glass) 1 ml (30 mg/ml)
1 pre-filled 
syringe 
Subcutaneous 
use
pre-filled syringe (glass)
in pre-filled pen
1 ml (30 mg/ml)
1 pre-filled pen
